No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient

Buono, Andrea; Gori, Tommaso

doi:10.1016/j.ijcha.2019.100417

Cited by 6 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…according to previous studies [16,17]. In the present study, we observed that the incidence of NR was 22.7%, which was consistent with the aforementioned studies.…”

Section: Discussionsupporting

confidence: 93%

See 1 more Smart Citation

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Şimşek¹,

Çınar²,

Ozan³

et al. 2021

Kardiol Pol

View full text Add to dashboard Cite

“…according to previous studies [16,17]. In the present study, we observed that the incidence of NR was 22.7%, which was consistent with the aforementioned studies.…”

Section: Discussionsupporting

confidence: 93%

“…Informed consent was waived due to the retrospective design of the study. (17) 42 (14) 52 (17) 4, n (%) 65 (21) 65 (22) 58 (19) 5, n (%) 9 (3) 7 (2) 15 (5) No-reflow, n (%) 36 (12) 70 (23) 100 (33) <0.001…”

Section: Compliance With Ethical Standardsmentioning

confidence: 99%

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Şimşek¹,

Çınar²,

Ozan³

et al. 2021

Kardiol Pol

View full text Add to dashboard Cite

“…In particular, in STEMI patients undergoing primary PCI, the incidence of NR is significantly higher than in elective procedures, which may range from 5% to as high as 10% compared to in prior studies. [17][18][19] In the present analysis, we found that the incidence of NR was 8.9%, which was similar to the reported clinical studies. Although the underlying mechanisms causing NR have not been thoroughly elucidated, it has been shown that certain clinical and complete blood count parameters at admission, such as older age, white blood cell count, and hemoglobin levels can predict the occurrence of NR in STEMI patients undergoing primary PCI.…”

Section: Discussionsupporting

confidence: 92%

The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction

Selçuk¹,

Çınar²,

Şaylık

et al. 2021

Angiology

View full text Add to dashboard Cite

This study aimed to evaluate the association of admission PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy (PRECISE-DAPT) score with the development of no-reflow (NR) in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). In this observational, retrospective study, 335 consecutive STEMI patients who were treated with primary PCI were included. We classified the study population into 2 groups: patients with a PRECISE-DAPT score <25 and those with a PRECISE-DAPT score ≥25. Overall, 30 (8.9%) patients developed NR. The mean PRECISE-DAPT score (20.03 ± 15.32 vs 11.33 ± 12.18; P = .005) was significantly higher in cases who developed NR. Moreover, arrhythmic complications, in-hospital shock, and in-hospital mortality rates were significantly higher in patients with a PRECISE-DAPT score ≥25 compared to those with a PRECISE-DAPT score <25. According to a multivariable analysis, the PRECISE-DAPT score was found to be independently linked with NR (odds ratio: 2.87, with P = .015). To our knowledge, these data are the first in major medical science databases to determine the relationship between the PRECISE-DAPT score and the NR phenomenon in patients with STEMI undergoing primary PCI.

show abstract

“…Initial markers of cardiac injury for patients with true STEMI in the COVID-19 era were not significantly higher than those with true STEMI before the COVID-19 era, suggesting that patients in our geographic location may not be waiting longer at home before presenting to the hospital for care. Furthermore, the rates of no reflow phenomenon and high thrombus burden, both markers of delayed presentation for STEMI [6], and allcause mortality were not different in our limited number of patients with true STEMI before and during the COVID-19 era. This may be due to the fact that the number of patients infected with COVID-19 in Los Angeles County [7] has not been as high as other regions of the country.…”

Section: Discussionmentioning

confidence: 59%

Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic

et al. 2020

View full text Add to dashboard Cite

Background:The coronavirus disease 2019 (COVID-19) pandemic has greatly affected healthcare delivery across the world. In this report, we aim to further characterize the changes in cardiac catheterization at our institution, specifically in the setting of acute coronary syndrome (ACS). Methods:We performed a retrospective analysis of patients undergoing cardiac catheterization between December 23, 2019 and April 12, 2020 at our institution. All patients with cardiac catheterizations for ACS, ST-elevation myocardial infarction (STEMI) activation, and out-of-hospital cardiac arrest (OHCA) were analyzed. Cardiac catheterization volume, as well as clinical and procedural characteristics of patients undergoing cardiac catheterization, was compared before and during the COVID-19 pandemic.Results: Patients presenting with ACS and OHCA were similar in terms of demographics and comorbidities during both time periods. The mean monthly volume for ACS cases dropped by 26% during the pandemic, which was consistent among both unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) and STEMI cases. OHCA volume decreased significantly as well (five cases per month before to zero cases during the pandemic, P = 0.01). Among patients with STEMI, initial markers of cardiac injury, door-to-balloon time, and all-cause mortality were similar in both time periods. Conclusions:With the start of the COVID-19 pandemic, there was a reduction in cardiac catheterization volume across the spectrum of ACS at our institution, which was consistent with reports from other centers across the globe. Patients with STEMI during the initial phase of the COVID-19 pandemic did not seem to have delays in presentation or significant differences in all-cause mortality at our institution.

show abstract

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient

Cited by 6 publications

References 16 publications

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction

Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic

Contact Info

Product

Resources

About

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient

Cited by 6 publications

References 16 publications

The association of acute­-to­-chronic glycemic ratio with no-reflow in patients with ST­-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

The association of acute­-to­-chronic glycemic ratio with no-reflow in patients with ST­-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction

Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic

Contact Info

Product

Resources

About

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

The association of acute-to-chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention